Return

DHEA Sulfate, LC/MS-MS (Endocrine Sciences)

Code:9031|CPT:82627|LOINC:2191-5

Synonyms
Дигидротестостерон сульфатаДЭА-С5-Dehydroepiandrosterone (5-DHEA)DHEA-SDehydroepiandrosterone SulfateDihydrotestosterone sulfate
IncludesDHEA-Sulfate, LCMS

Analysis details

Methodology

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
  • Chemiluminescent immunoassay (CLIA)

Expected Turnaround Time

1 day

Special Instructions

  • Avoid eating for 2–3 hours before the blood draw; water is allowed.
  • With the ordering clinician’s approval, stop steroid and thyroid hormone medications 48 hours before collection.
  • Refrain from strenuous exercise and significant emotional stress for 24 hours prior to collection.
  • Do not smoke during the 3 hours before collection.
  • Testing is performed at Endocrine Sciences; specimens may be stored for up to 90 days.

How to use

The DHEA Sulfate, LC/MS-MS (Endocrine Sciences) test—also known as dehydroepiandrosterone sulfate or DHEA‑S—assesses adrenal androgen output and helps distinguish an adrenal from an ovarian or testicular origin of androgen excess. It is used in the evaluation of hirsutism and virilization, including polycystic ovary syndrome, and in adrenocortical disorders such as congenital adrenal hyperplasia and adrenal tumors/carcinoma. The assay supports the workup of infertility and amenorrhea and aids in assessing disorders of sex development. DHEA‑S levels are generally low in Addison disease and are characteristically not elevated with hypopituitarism.

Limitations

Dehydroepiandrosterone sulfate (DHEA‑S) is an androgen found in both males and females that serves as a precursor convertible to more potent androgens (testosterone, androstenedione) as well as to estrogens. Its synthesis is regulated by adrenocorticotropic hormone (ACTH) and other pituitary signals, making it a useful indicator of adrenal function. Adrenal hyperplasia and adrenal tumors/carcinoma may raise DHEA‑S concentrations. Elevated levels can be clinically silent in men, whereas in women they are associated with amenorrhea and virilization. In pediatric populations, excessive production contributes to precocious puberty in boys and to virilization, hirsutism, and menstrual irregularity in girls.

Unitmcg/dL
Reference interval
MaleFemale
16.4–592.98.2–513.7

Depends on your age

IndicationsSuspected androgen excess with assessment of adrenal androgen production, Source localization of androgen excess (adrenal versus ovarian or testicular), Evaluation of amenorrhea, Workup of female infertility, Assessment of virilizing features in women (e.g., hirsutism, voice deepening, male‑pattern alopecia, acne), Evaluation of ambiguous genitalia or other disorders of sex development in girls, Assessment of precocious puberty in boys

Possible Causes of Abnormal Results

Increased levels

  • dhea-s supplementation
  • newborn period (physiologic)

Decreased levels

  • aging

Specimen Requirements

SpecimenSerum
ContainerGold/Tiger Top (SST, Gel Separator)
Volume0.2 mL (min 0.1 mL)
Storage InstructionsRoom temperature, Refrigerated, Frozen